KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Cash & Current Investments (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Cash & Current Investments for 7 consecutive years, with $101.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments fell 47.87% year-over-year to $101.4 million, compared with a TTM value of $101.4 million through Dec 2025, down 47.87%, and an annual FY2025 reading of $101.4 million, down 47.87% over the prior year.
  • Cash & Current Investments was $101.4 million for Q4 2025 at Clover Health Investments, down from $191.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $590.1 million in Q2 2021 and bottomed at $101.4 million in Q4 2025.
  • Average Cash & Current Investments over 5 years is $286.1 million, with a median of $289.2 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments skyrocketed 169870.41% in 2021, then tumbled 55.76% in 2023.
  • Year by year, Cash & Current Investments stood at $321.1 million in 2021, then fell by 8.66% to $293.3 million in 2022, then tumbled by 55.76% to $129.8 million in 2023, then soared by 49.93% to $194.6 million in 2024, then crashed by 47.87% to $101.4 million in 2025.
  • Business Quant data shows Cash & Current Investments for CLOV at $101.4 million in Q4 2025, $191.9 million in Q3 2025, and $190.4 million in Q2 2025.